T cell malignancies after CAR T cell therapy in the DESCAR-T registry - Nature Medicine This analysis of the registry database DESCAR-T of more than 3,000 pediatric and adult patients with hematological malignancies who received CAR T cell therapy in France between 2018 and 2024 shows th...

Happy to share our work published in Nature Medicine!

We analyzed 3,066 patients from the French DESCAR-T registry who received #CARTcell therapy. Our findings indicate a very low risk of T-cell malignancy after CAR T-cell therapy: only 1 case (0.03%). www.nature.com/articles/s41...

#Cancer rant time 🫠

"Sid why do you care so much about getting accurate information out about medicine?"

Because of stuff like this. Just yesterday this was blasted across the airwaves. Apparently we have the cure for stage 4 cancer don't you know?

#ASH24 News: Studies Highlight Progress in Preventing and Treating Blood Cancers and Pre-Cancerous Conditions: bit.ly/3Znusbb #Hematology #HemeSky

🙋🏽‍♂️

If you're interested in Stem cell transplant and/or Cellular Therapy this is the list #bmtsm #CARTcells #leusm #mmsm #lymsm #MedSky #TcellRx go.bsky.app/7xxh8WW